| Amgen (AMGN) |
United States |
$145.088B |
15.76 |
| Bristol Myers Squibb (BMY) |
United States |
$134.110B |
10.33 |
| CSL (CSLLY) |
Australia |
$93.977B |
0.00 |
| Gilead Sciences (GILD) |
United States |
$81.555B |
11.74 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$69.125B |
38.57 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$59.073B |
22.59 |
| Biogen (BIIB) |
United States |
$43.454B |
7.44 |
| Illumina (ILMN) |
United States |
$43.143B |
50.17 |
| Seattle Genetics (SGEN) |
United States |
$31.483B |
0.00 |
| Moderna (MRNA) |
United States |
$27.570B |
0.00 |
| Genmab (GMAB) |
Denmark |
$25.300B |
15.98 |
| Alexion Pharmaceuticals (ALXN) |
United States |
$24.924B |
10.39 |
| BeiGene (BGNE) |
Cayman Islands |
$24.766B |
0.00 |
| Genmab (GNMSF) |
Denmark |
$23.997B |
5.53 |
| SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$21.148B |
0.00 |
| Immunomedics (IMMU) |
United States |
$19.770B |
0.00 |
| Incyte (INCY) |
United States |
$18.981B |
0.00 |
| Horizon Therapeutics Public (HZNP) |
Ireland |
$16.502B |
38.61 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$15.338B |
0.00 |
| BioNTech SE (BNTX) |
Germany |
$15.160B |
0.00 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$15.059B |
68.11 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$14.396B |
104.45 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$11.740B |
0.00 |
| Exact Sciences (EXAS) |
United States |
$11.633B |
0.00 |
| QIAGEN (QGEN) |
Netherlands |
$11.522B |
29.24 |
| Sarepta Therapeutics (SRPT) |
United States |
$11.346B |
0.00 |
| Guardant Health (GH) |
United States |
$10.191B |
0.00 |
| Bio-Techne Corp (TECH) |
United States |
$9.404B |
64.52 |
| Galapagos (GLPG) |
Belgium |
$9.087B |
32.92 |
| Exelixis (EXEL) |
United States |
$8.281B |
30.11 |
| SWEDISH ORP BIO (BIOVF) |
Sweden |
$7.799B |
19.40 |
| Ascendis Pharma (ASND) |
Denmark |
$7.768B |
0.00 |
| Repligen (RGEN) |
United States |
$7.665B |
121.66 |
| MyoKardia (MYOK) |
United States |
$7.238B |
0.00 |
| Mirati Therapeutics (MRTX) |
United States |
$7.175B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$6.689B |
0.00 |
| Novavax (NVAX) |
United States |
$6.640B |
0.00 |
| Acceleron Pharma (XLRN) |
United States |
$6.383B |
0.00 |
| Adaptive Biotechnologies (ADPT) |
United States |
$6.294B |
0.00 |
| Momenta Pharmaceuticals (MNTA) |
United States |
$6.220B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$6.028B |
186.74 |
| Emergent Biosolutions (EBS) |
United States |
$5.324B |
21.09 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$5.021B |
0.00 |
| Zai Lab (ZLAB) |
China |
$4.606B |
0.00 |
| MorphoSys AG (MOR) |
Germany |
$4.503B |
59.02 |
| China Biologic Products (CBPO) |
China |
$4.408B |
26.16 |
| Blueprint Medicines (BPMC) |
United States |
$4.391B |
0.00 |
| Vir Biotechnology (VIR) |
United States |
$4.157B |
0.00 |
| Legend Biotech (LEGN) |
United States |
$4.136B |
0.00 |
| Arena Pharmaceuticals (ARNA) |
United States |
$4.107B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$4.092B |
0.00 |
| NeoGenomics (NEO) |
United States |
$3.957B |
1194.33 |
| Halozyme Therapeutics (HALO) |
United States |
$3.801B |
0.00 |
| Amicus Therapeutics (FOLD) |
United States |
$3.778B |
0.00 |
| Bluebird Bio (BLUE) |
United States |
$3.752B |
0.00 |
| Reata Pharmaceuticals (RETA) |
United States |
$3.545B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$3.409B |
0.00 |
| Global Blood Therapeutics (GBT) |
United States |
$3.395B |
0.00 |
| Insmed (INSM) |
United States |
$3.386B |
0.00 |
| Principia Biopharma (PRNB) |
United States |
$3.330B |
0.00 |
| Deciphera Pharmaceuticals (DCPH) |
United States |
$3.161B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$3.029B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$2.868B |
60.10 |
| Inovio Pharmaceuticals (INO) |
United States |
$2.848B |
0.00 |
| PHARMA MAR SA (PHMMF) |
Spain |
$2.290B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$2.282B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$2.117B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$2.111B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$2.106B |
0.00 |
| Mesoblast (MESO) |
Australia |
$2.098B |
0.00 |
| I-Mab (IMAB) |
China |
$2.092B |
0.00 |
| Zymeworks (ZYME) |
Canada |
$2.069B |
0.00 |
| Eidos Therapeutics (EIDX) |
United States |
$2.034B |
0.00 |
| BAVARIAN NORDIC (BVNRY) |
Denmark |
$2.006B |
22.47 |
| Seres Therapeutics (MCRB) |
United States |
$1.956B |
0.00 |
| Forma Therapeutics Holdings (FMTX) |
United States |
$1.862B |
0.00 |
| UniQure (QURE) |
Netherlands |
$1.853B |
0.00 |
| Akcea Therapeutics (AKCA) |
United States |
$1.844B |
0.00 |
| Viela Bio (VIE) |
United States |
$1.628B |
0.00 |
| Amarin (AMRN) |
Ireland |
$1.607B |
0.00 |
| Cytokineticsorporated (CYTK) |
United States |
$1.537B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$1.525B |
0.00 |
| Beam Therapeutics (BEAM) |
United States |
$1.524B |
0.00 |
| Mersana Therapeutics (MRSN) |
United States |
$1.509B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$1.480B |
50.04 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$1.478B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$1.451B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$1.424B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.422B |
8.29 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$1.382B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$1.381B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$1.357B |
0.00 |
| Epizyme (EPZM) |
United States |
$1.346B |
0.00 |
| Zealand Pharma (ZLDPF) |
Denmark |
$1.339B |
0.00 |
| NGM Biopharmaceuticals (NGM) |
United States |
$1.317B |
0.00 |
| Compugen (CGEN) |
Israel |
$1.290B |
0.00 |
| Alcobra (ARCT) |
United States |
$1.144B |
0.00 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$1.137B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$1.118B |
0.00 |
| Alector (ALEC) |
United States |
$1.115B |
0.00 |
| Arvinas (ARVN) |
United States |
$1.098B |
0.00 |
| Athenex (ATNX) |
United States |
$1.073B |
0.00 |
| Retrophin (RTRX) |
United States |
$1.031B |
0.00 |
| Castle Biosciences (CSTL) |
United States |
$1.005B |
0.00 |
| Pliant Therapeutics (PLRX) |
United States |
$1.000B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$0.999B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$0.966B |
0.00 |
| Agenus (AGEN) |
United States |
$0.950B |
0.00 |
| Heska (HSKA) |
United States |
$0.933B |
0.00 |
| NantKwest (NK) |
United States |
$0.917B |
0.00 |
| Morphic Holding (MORF) |
United States |
$0.885B |
0.00 |
| Cellectis S.A (CLLS) |
France |
$0.885B |
0.00 |
| Vericel (VCEL) |
United States |
$0.865B |
0.00 |
| OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$0.842B |
0.00 |
| Frequency Therapeutics (FREQ) |
United States |
$0.840B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.828B |
0.00 |
| Intrexon (PGEN) |
United States |
$0.810B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$0.810B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$0.770B |
0.00 |
| Codexis (CDXS) |
United States |
$0.720B |
0.00 |
| MiMedx (MDXG) |
United States |
$0.715B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.714B |
16.29 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.712B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$0.681B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$0.670B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.656B |
0.00 |
| AC Immune SA (ACIU) |
Switzerland |
$0.644B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.642B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.640B |
43.13 |
| Clovis Oncology (CLVS) |
United States |
$0.614B |
0.00 |
| Geron (GERN) |
United States |
$0.609B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.596B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$0.595B |
0.00 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.591B |
0.00 |
| Albireo Pharma (ALBO) |
United States |
$0.583B |
0.00 |
| Aquinox Pharmaceuticals (NLTX) |
United States |
$0.580B |
0.00 |
| IVERIC Bio (ISEE) |
United States |
$0.563B |
0.00 |
| Forte Biosciences (FBRX) |
United States |
$0.555B |
0.00 |
| Kala Pharmaceuticals (KALA) |
United States |
$0.551B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$0.543B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.538B |
4.71 |
| Anika Therapeutics (ANIK) |
United States |
$0.519B |
22.70 |
| Cue Biopharma (CUE) |
United States |
$0.510B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$0.506B |
0.00 |
| MeiraGTx Holdings (MGTX) |
United States |
$0.506B |
0.00 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$0.503B |
0.00 |
| MannKind (MNKD) |
United States |
$0.477B |
0.00 |
| UROGEN PHARMA (URGN) |
United States |
$0.470B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.458B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.457B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$0.449B |
0.00 |
| AnaptysBio (ANAB) |
United States |
$0.439B |
0.00 |
| Athersys (ATHX) |
United States |
$0.430B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.426B |
0.00 |
| Prothena (PRTA) |
Ireland |
$0.425B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.421B |
0.00 |
| Amryt Pharma (AMYT) |
United Kingdom |
$0.414B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.411B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.411B |
29.07 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.400B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.390B |
18.66 |
| PDL BioPharma (PDLI) |
United States |
$0.380B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.376B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.374B |
8.83 |
| Cellular Biomedicine (CBMG) |
United States |
$0.363B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.351B |
0.00 |
| Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.351B |
0.00 |
| AMAG Pharmaceuticals (AMAG) |
United States |
$0.349B |
0.00 |
| Trevena (TRVN) |
United States |
$0.342B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.342B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.311B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.304B |
0.00 |
| Innate Pharma S.A (IPHA) |
France |
$0.302B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.290B |
0.00 |
| Cyclerion Therapeutics (CYCN) |
United States |
$0.285B |
0.00 |
| Prometic Life Sciences (LMNL) |
Canada |
$0.282B |
0.00 |
| OSMOTICA PHARM (OSMT) |
United States |
$0.281B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.279B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.275B |
0.00 |
| NextCure (NXTC) |
United States |
$0.263B |
0.00 |
| Arbutus Biopharma (ABUS) |
United States |
$0.260B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.258B |
0.00 |
| HOOKIPA Pharma (HOOK) |
United States |
$0.240B |
0.00 |
| Verastem (VSTM) |
United States |
$0.236B |
0.00 |
| Aduro Biotech (ADRO) |
United States |
$0.224B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.222B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.222B |
0.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.219B |
0.00 |
| XOMA (XOMA) |
United States |
$0.218B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.214B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.214B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.208B |
0.00 |
| Cerecor (CERC) |
United States |
$0.208B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.206B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.204B |
0.00 |
| Cardiff Oncology (CRDF) |
United States |
$0.202B |
0.00 |
| Theratechnologies (THTX) |
Canada |
$0.201B |
0.00 |
| Biofrontera AG (BFRA) |
Germany |
$0.200B |
0.00 |
| Eton Pharmaceuticals (ETON) |
United States |
$0.190B |
0.00 |
| POXEL SA FRANCE (PXXLF) |
France |
$0.188B |
0.00 |
| GENFIT S.A (GNFT) |
France |
$0.179B |
0.00 |
| Exicure (XCUR) |
United States |
$0.179B |
0.00 |
| Nymox Pharmaceutical (NYMX) |
Canada |
$0.177B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.176B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.174B |
8.10 |
| Aytu Bioscience (AYTU) |
United States |
$0.166B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.166B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.163B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.161B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.155B |
0.00 |
| Nicox SA (NICXF) |
France |
$0.149B |
0.00 |
| SESEN BIO, INC (SESN) |
United States |
$0.148B |
0.00 |
| Five Prime Therapeutics (FPRX) |
United States |
$0.148B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.147B |
0.00 |
| Bellus Health (BLU) |
Canada |
$0.147B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.141B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.136B |
0.00 |
| Cidara Therapeutics (CDTX) |
United States |
$0.134B |
0.00 |
| Catabasis Pharmaceuticals (CATB) |
United States |
$0.134B |
0.00 |
| Gritstone Oncology (GRTS) |
United States |
$0.125B |
0.00 |
| Lumos Pharma (LUMO) |
United States |
$0.121B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.120B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.118B |
6.02 |
| Vaccinex (VCNX) |
United States |
$0.114B |
0.00 |
| Unum Therapeutics (UMRX) |
United States |
$0.112B |
0.00 |
| Windtree Therapeutics (WINT) |
United States |
$0.112B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.111B |
0.00 |
| PHASEBIO PHARMA (PHAS) |
United States |
$0.107B |
0.00 |
| Antibe Therapeutics (ATBPF) |
Canada |
$0.107B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.106B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.100B |
0.00 |
| AIT Therapeutics (XAIR) |
United States |
$0.098B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.094B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.088B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$0.085B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.082B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.080B |
0.00 |
| Adocia (ADOCY) |
France |
$0.080B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.080B |
0.00 |
| Ecology Coatings (ABVC) |
United States |
$0.078B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.074B |
0.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.074B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.073B |
0.00 |
| Edesa Biotech (EDSA) |
Canada |
$0.073B |
0.00 |
| Proteostasis Therapeutics (PTI) |
United States |
$0.066B |
0.00 |
| Aridis Pharmaceuticals (ARDS) |
United States |
$0.066B |
0.00 |
| Aerpio Pharmaceuticals (ARPO) |
United States |
$0.063B |
0.00 |
| Emmaus Life Sciences (EMMA) |
United States |
$0.063B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.061B |
0.00 |
| Curis (CRIS) |
United States |
$0.060B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.060B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.055B |
0.00 |
| AnPac Bio-Medical Science (ANPC) |
China |
$0.054B |
0.00 |
| Stealth BioTherapeutics (MITO) |
United States |
$0.053B |
76.25 |
| Appili Therapeutics (APLIF) |
Canada |
$0.052B |
0.00 |
| Cocrystal Pharma (COCP) |
United States |
$0.052B |
0.00 |
| Happiness Biotech Group (HAPP) |
China |
$0.051B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.051B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.049B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.049B |
0.00 |
| Signal Genetics (MGEN) |
United States |
$0.048B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.047B |
0.00 |
| CollPlant Holdings (CLGN) |
Israel |
$0.047B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.045B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.044B |
0.00 |
| ATyr Pharma (LIFE) |
United States |
$0.041B |
0.00 |
| Chanticleer Holdings (SONN) |
United States |
$0.038B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.033B |
0.00 |
| OvaScience (MLND) |
United States |
$0.031B |
0.00 |
| BioCardia (BCDA) |
United States |
$0.030B |
0.00 |
| Apricus Biosciences (SEEL) |
United States |
$0.030B |
0.00 |
| Advaxis (ADXS) |
United States |
$0.029B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.029B |
0.00 |
| Sunesis Pharmaceuticals (SNSS) |
United States |
$0.028B |
0.00 |
| Cleveland BioLabs (CBLI) |
United States |
$0.027B |
0.00 |
| Celsion (CLSN) |
United States |
$0.026B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.026B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.025B |
0.00 |
| Cesca Therapeutics (THMO) |
United States |
$0.024B |
0.00 |
| Spherix (AIKI) |
United States |
$0.021B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.020B |
0.00 |
| AEterna Zentaris (AEZS) |
United States |
$0.020B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.018B |
0.00 |
| MYOS RENS Technology (MYOS) |
United States |
$0.018B |
0.00 |
| Neuralstem (SNCA) |
United States |
$0.010B |
0.00 |
| Benitec Biopharma (BNTC) |
Australia |
$0.008B |
0.00 |
| Entera Bio (ENTX) |
Israel |
$0.000B |
0.00 |
